0001237899-14-000023.txt : 20140219 0001237899-14-000023.hdr.sgml : 20140219 20140219161232 ACCESSION NUMBER: 0001237899-14-000023 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140214 FILED AS OF DATE: 20140219 DATE AS OF CHANGE: 20140219 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Aberman Michael S CENTRAL INDEX KEY: 0001487767 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 14625806 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2014-02-14 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001487767 Aberman Michael S 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 VP Strategy and Investor Relat Common Stock 2014-02-14 4 M 0 7500.0 30.63 A 23100 D Common Stock 2014-02-14 4 F 0 710.0 323.3 D 22390 D Common Stock 2014-02-14 4 F 0 3142.0 323.3 D 19248 D Common Stock 2014-02-18 4 S 0 100.0 324.81 D 19148 D Common Stock 2014-02-18 4 S 0 200.0 325.36 D 18948 D Common Stock 2014-02-18 4 S 0 300.0 327.56 D 18648 D Common Stock 2014-02-18 4 S 0 100.0 328.6 D 18548 D Common Stock 2014-02-18 4 S 0 200.0 329.34 D 18348 D Common Stock 2014-02-18 4 S 0 200.0 330.87 D 18148 D Common Stock 2014-02-18 4 S 0 200.0 331.16 D 17948 D Common Stock 2014-02-18 4 S 0 1100.0 332.41 D 16848 D Common Stock 2014-02-18 4 S 0 948.0 333.5 D 15900 D Common Stock 2014-02-18 4 S 0 300.0 334.24 D 15600 D Common Stock 376 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 30.63 2014-02-14 4 M 0 7500.0 0.0 D 2020-12-14 Common Stock 7500 15000 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 200 shares of Company stock on February 18, 2014 at prices ranging from $325.11 to $325.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 18, 2014 at each separate price. Represents volume-weighted average price of sales of 300 shares of Company stock on February 18, 2014 at prices ranging from $327.00 to $327.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 18, 2014 at each separate price. Represents volume-weighted average price of sales of 200 shares of Company stock on February 18, 2014 at prices ranging from $329.05 to $329.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 18, 2014 at each separate price. Represents volume-weighted average price of sales of 200 shares of Company stock on February 18, 2014 at prices ranging from $330.82 to $330.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 18, 2014 at each separate price. Represents volume-weighted average price of sales of 200 shares of Company stock on February 18, 2014 at prices ranging from $331.01 to $331.31. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 18, 2014 at each separate price. Represents volume-weighted average price of sales of 1,100 shares of Company stock on February 18, 2014 at prices ranging from $332.00 to $332.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 18, 2014 at each separate price. Represents volume-weighted average price of sales of 948 shares of Company stock on February 18, 2014 at prices ranging from $333.06 to $333.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 18, 2014 at each separate price. Represents volume-weighted average price of sales of 300 shares of Company stock on February 18, 2014 at prices ranging from $334.00 to $334.41. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 18, 2014 at each separate price. The stock option award vests in four equal annual installments, commencing one year after the date of grant. /s/**Michael S. Abergman 2014-02-18